Trial intelligence / Profile preview

Doxazosin GITS in Taiwanese Patients With Benign Prostate Hyperplasia

NCT00648323Phase 4Completed

Sponsor
Viatris
Start
Nov 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of doxazosin in benign prostatic hyperplasia (BPH), sponsored by Viatris. Started Nov 2003; status: completed.

02

Drugs

doxazosin
03

Conditions

benign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on NCT00648323.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00648323.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call